The North Jutland County Diabetic Retinopathy Study. Population characteristics [PDF]
Gorst-Rasmussen, Anders +3 more
core +1 more source
Diabetic Macular Oedema and Retinal Imaging
openaire +1 more source
Non-ophthalmic parameters and the presence of clinically significant macular oedema [PDF]
Gorst-Rasmussen, Anders +3 more
core +1 more source
Diabetic macular oedema (DMO): an introduction.
Rajiv, Raman, Raja, Narayanan
openaire +1 more source
Vascular Endothelial Growth Factors in Eye Diseases. Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis (Verisuonikasvutekijöiden merkitys silmäsairauksissa. Patofysiologiaa ja uusia hoitomenetelmiä verkkokalvon ja suonikalvon angiogeneettisiin sairauksiin) [PDF]
Kinnunen, Kati
core
New Drug: Faricimab for neovascular age-related macular degeneration and diabetic macular oedema
openaire +2 more sources
Related searches:
Diabetic macular oedema, characterised by exudative fluid accumulation in the macula, is the most common form of sight-threatening retinopathy in people with diabetes. It affects one in 15 people with diabetes resulting in more than 20 million cases worldwide.
Gavin S, Tan +4 more
openaire +2 more sources
FUNDUS AUTOFLUORSECNCE IN DIABETIC MACULAR OEDEMA
INDIAN JOURNAL OF APPLIED RESEARCH, 2022ntroduction: Diabetic macular oedema accounts for more than half the cases of vision loss in diabetics. With a shifting trend on early diagnosis and treatment of DME, fundus autouorescence may prove to be valuable. Traditional methods of 90d slit lamp examination and OCT may not detect early DME.
Uttara Pandit +2 more
openaire +1 more source
Therapeutic Options in Refractory Diabetic Macular Oedema
Drugs, 2017Diabetic macular oedema (DMO) results from alterations of several biochemical pathways in diabetic eyes. Centre-involving DMO is an important cause of visual loss in diabetes. Anti-vascular endothelial growth factor agents are now the mainstay of centre-involving DMO treatment.
Sanket U, Shah, Raj K, Maturi
openaire +2 more sources
[Pathogenesis of diabetic macular oedema].
Klinische Monatsblatter fur Augenheilkunde, 2004Hyperglycaemia causes breakdown of the blood retina barrier leading to formation of macular oedema and consecutive visual loss. Three major mechanisms are involved in barrier breakdown: increased paracellular permeability of vascular endothelium due to disruption of cell junctions, loss of endothelial cell layer integrity due to cell destruction, and ...
Tim U, Krohne +3 more
openaire +1 more source

